Omicron now dominant coronavirus strain in new U.S. cases
The Omicron variant accounted for 73 percent of new coronavirus cases between Dec. 12 and 18, the Centers for Disease Control and Prevention said on Monday.
The Delta variant has been the driving force in U.S. infections for more than five months, with CDC data showing that at the end of last month, more than 99.5 percent of coronavirus cases were Delta. Omicron was first detected in southern Africa in late November, and has since been found in 90 countries. It's estimated that last week, more than 650,000 Omicron infections were reported in the United States.
In New York, the Pacific Northwest, and the Southeast, it's believed that at least 90 percent of new infections are because of Omicron, The Associated Press reports. The numbers are "stark," CDC Director Dr. Rochelle Walensky said, but "they're not surprising," as they follow the growth seen in other countries. She also anticipates that over time, "Delta will be crowded out by Omicron."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Researchers are still trying to determine if Omicron causes a more severe illness; both Moderna and Pfizer have said in lab tests, a third dose of their COVID-19 vaccines increased immune response against Omicron. Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, told AP he expects Omicron will further spread during the holidays.
"All of us have a date with Omicron," Adalja said. "If you're going to interact with society, if you're going to have any type of life, Omicron will be something you encounter, and the best way you can encounter this is to be fully vaccinated."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Without Cuba, US State Sponsors of Terrorism list shortens
The Explainer How the remaining three countries on the U.S. terrorism blacklist earned their spots
By David Faris Published
-
Codeword: January 21, 2025
The Week's daily codeword puzzle
By The Week Staff Published
-
Crossword: January 21, 2025
The Week's daily crossword
By The Week Staff Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Kidney stones are affecting children far more than they once did
Under the radar Salt may be to blame
By Devika Rao, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published